Lilly To Cut Some List Prices By 70% And Offer $25 Insulin
By Bhanvi Satija and Patrick Wingrove (Reuters) -Eli Lilly and Co on Wednesday said it will cut list prices by 70% for its most commonly prescribed insulin products, Humalog and Humulin, beginning from the fourth quarter of this year. The Indianapolis-based drugmaker also will lower the price of its Lispro insulin injection to $25 a…